Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William Garner
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Potential Long-Term Cost Savings in Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) in the Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (FTC/TAF) vs. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by Third Agent of a Randomized, Double-Blind, Active-Controlled Phase 3 Trial
HIV Clinical Trials
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
ISRN Gastroenterology
Should We Fear Resistance From Tenofovir/Emtricitabine Preexposure Prophylaxis?
Current Opinion in HIV and AIDS
Virology
Oncology
Infectious Diseases
Immunology
Hematology
Metabolic Evaluation of Study M05-730: LPV/r Tablets QD vs. BID, Co-Administered With Tenofovir DF + Emtricitabine in ARV-naïve HIV-1 Infected Subjects
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Is Tenofovir/Emtricitabine Teratogenic?
Therapeutic Advances in Drug Safety
Pharmacology
Fosamprenavir or Atazanavir Once Daily Boosted With Ritonavir 100mg, Plus Tenofovir/Emtricitabine, for the Initial Treatment of HIV Infection: 48-Week Results of ALERT
AIDS Research and Therapy
Virology
Molecular Medicine
Pharmacology
Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
